Trials / Completed
CompletedNCT00717756
Lenalidomide for Advanced Hepatocellular Cancer:A Phase II Trial
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 41 (actual)
- Sponsor
- Brown University · Academic / Other
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
This study will determine whether lenalidomide has activity in patients with advanced liver cancer that have had growth of their cancer after sorafenib.
Detailed description
This study will determine the response rate and toxicities of lenalidomide as second line treatment for patients with liver cancer who have progressed after sorafenib.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | lenalidomide | 25 mg po qd x 21 days then 1 week off equals one cycle |
Timeline
- Start date
- 2009-01-01
- Primary completion
- 2013-12-01
- Completion
- 2014-01-01
- First posted
- 2008-07-17
- Last updated
- 2020-02-17
- Results posted
- 2014-04-03
Locations
3 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00717756. Inclusion in this directory is not an endorsement.